Literature DB >> 21617158

Allogeneic mesenchymal stem cell transplantation in seven patients with refractory inflammatory bowel disease.

Jun Liang, Huayong Zhang, Dandan Wang, Xuebing Feng, Hong Wang, Bingzhu Hua, Bujun Liu, Lingyun Sun.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21617158     DOI： 10.1136/gutjnl-2011-300083

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  50 in total

Review 1.  Stem cell therapy in inflammatory bowel disease: A promising therapeutic strategy?

Authors:  Ana I Flores; Gonzalo J Gómez-Gómez; Ángeles Masedo-González; M Pilar Martínez-Montiel
Journal:  World J Stem Cells       Date:  2015-03-26       Impact factor: 5.326

2.  Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy.

Authors:  Fei Gu; Dandan Wang; Huayong Zhang; Xuebing Feng; Gary S Gilkeson; Songtao Shi; Lingyun Sun
Journal:  Clin Rheumatol       Date:  2014-08-14       Impact factor: 2.980

3.  Long-term results of adipose-derived stem cell therapy for the treatment of Crohn's fistula.

Authors:  Yong Beom Cho; Kyu Joo Park; Sang Nam Yoon; Kee Ho Song; Do Sun Kim; Sang Hun Jung; Mihyung Kim; Hee Young Jeong; Chang Sik Yu
Journal:  Stem Cells Transl Med       Date:  2015-03-31       Impact factor: 6.940

Review 4.  Stem cell transplant in inflammatory bowel disease: a promising modality of treatment for a complicated disease course.

Authors:  George A Salem; George B Selby
Journal:  Stem Cell Investig       Date:  2017-11-29

Review 5.  Molecular and Cellular Mechanisms Involved in Mesenchymal Stem Cell-Based Therapy of Inflammatory Bowel Diseases.

Authors:  Bojana Simovic Markovic; Tatjana Kanjevac; C Randall Harrell; Marina Gazdic; Crissy Fellabaum; Nebojsa Arsenijevic; Vladislav Volarevic
Journal:  Stem Cell Rev Rep       Date:  2018-04       Impact factor: 5.739

6.  Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.

Authors:  Andrea Taddio; Alberto Tommasini; Erica Valencic; Ettore Biagi; Giuliana Decorti; Sara De Iudicibus; Eva Cuzzoni; Giuseppe Gaipa; Raffaela Badolato; Alberto Prandini; Andrea Biondi; Alessandro Ventura
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

7.  Conditioned mesenchymal stem cells produce pleiotropic gut trophic factors.

Authors:  Shuhei Watanabe; Yoshiaki Arimura; Kanna Nagaishi; Hiroyuki Isshiki; Kei Onodera; Masanao Nasuno; Kentaro Yamashita; Masashi Idogawa; Yasuyoshi Naishiro; Masaki Murata; Yasushi Adachi; Mineko Fujimiya; Kohzoh Imai; Yasuhisa Shinomura
Journal:  J Gastroenterol       Date:  2013-11-12       Impact factor: 7.527

Review 8.  Therapy with stem cells in inflammatory bowel disease.

Authors:  María Del Pilar Martínez-Montiel; Gonzalo Jesús Gómez-Gómez; Ana Isabel Flores
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 9.  Mesenchymal stem cell-based therapy.

Authors:  Vaibhav Mundra; Ivan C Gerling; Ram I Mahato
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

Review 10.  Stem cell-based therapies in inflammatory bowel disease: promises and pitfalls.

Authors:  Natalie E Duran; Daniel W Hommes
Journal:  Therap Adv Gastroenterol       Date:  2016-04-25       Impact factor: 4.409
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.